Berman Capital Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$0	Sell	15 -14	-48%	–	﹤0.01%	2116
2021 Q2	$2K	Sell	29 -103	-78%	-$7.1K	﹤0.01%	1588
2021 Q1	$10K	Buy	+132	New	+$10K	﹤0.01%	1027